The role of phase separation in a transcriptional repression mechanism relevant to Candida albicanspathogenesis.

相分离在与白色念珠菌发病机制相关的转录抑制机制中的作用。

基本信息

  • 批准号:
    10693886
  • 负责人:
  • 金额:
    $ 4.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary: Candida albicans is an opportunistic fungal pathogen capable of causing mucosal and systemic disease. Oropharyngeal candidiasis (OPC) is a frequent fungal disease in humans, and can potentially spread to other locations in the body causing systemic infections. Even with clinical intervention, systemic candidiasis has a mortality rate of ~40%. OPC involves the formation of biofilms in the oral mucosa that contain multiple C. albicans morphotypes, including both yeast and hyphal cells. The ability of C. albicans to form different cell types is crucial for virulence and contributes to its capacity to colonize different host tissues. The transition between yeast and hyphal cells is regulated by a network of transcription factors (TFs) that include the co-repressor Ssn6. Deletion of Ssn6 blocks formation of hyphal cells and attenuates C. albicans virulence. Ssn6 is also integral to a second TF network that regulates transitions between ‘white’ and ‘opaque’ states that exhibit different tissue tropisms in the host. Importantly, the Bennett lab has uncovered that multiple TFs (including Ssn6) in both networks contain prion-like domains (PrLDs) and that these can promote phase separation of the corresponding proteins. Phase separation refers to the process of liquid demixing that can generate protein condensates with liquid-like properties. This phenomenon is now implicated in the formation of many cellular structures including nucleoli, Cajal bodies, stress granules, and transcriptional complexes. While a number of studies on TF phase separation have been conducted, these studies primarily focus on transcriptional activators and not on transcriptional co-repressors such as Ssn6. Previous work in our lab has shown that C. albicans TFs containing PrLDs readily form phase-separated condensates when purified or when expressed in mammalian cells. Moreover, deletion or mutation of PrLDs can eliminate the ability of these TFs to function in C. albicans cells. My preliminary data shows Ssn6 is also able to form condensates, both individually and with other fungal TFs. I hypothesize that phase separation plays a key role in the ability of Ssn6 to act as a co-repressor in regulating cell morphology, and that it will contribute to virulence during OPC. In Aim 1, I will examine the biochemical properties of Ssn6 condensates. In Aim 2, I will address how changes to Ssn6 properties impact C. albicans morphotypes in vitro as well as virulence using a mouse model of OPC. Additionally, the goals of this fellowship include developing skill sets in order to lead a successful research career. Attending conferences, presenting to the department and graduate program, and regular meetings with the sponsor are planned to this end. The training plan will be carried out in an environment that benefits from the Molecular Biology, Cell Biology, and Biochemistry Graduate Program. Completion of the proposed goals will advance both the field of Candida biology and the ability of the recipient to become an effective independent scientific researcher.
项目概述:白色念珠菌是一种机会性真菌病原体, 全身性疾病。口咽念珠菌病是一种常见的人类真菌性疾病, 扩散到身体的其他部位,引起全身感染。即使有临床干预, 念珠菌病的死亡率约为40%。OPC涉及口腔粘膜中生物膜的形成, 多重C.白色念珠菌形态型,包括酵母和菌丝细胞。C.白色念珠菌形成 不同的细胞类型对毒力至关重要,并有助于其在不同宿主组织中定殖的能力。 酵母细胞和菌丝细胞之间的转换受转录因子(TF)网络的调节, 包括辅阻遏物Ssn6。Ssn6的缺失阻断了菌丝细胞的形成并减弱了C.白色 毒性Ssn6也是第二个TF网络的组成部分,该网络调节“白色”和“不透明”之间的转换。 在宿主中表现出不同组织向性的状态。重要的是,班尼特实验室发现, 两个网络中的TF(包括Ssn6)都含有朊病毒样结构域(PrLD),这些结构域可以促进阶段性 分离相应的蛋白质。相分离是指液体分层的过程, 产生具有液体性质的蛋白质缩合物。这种现象现在被牵连到形成 许多细胞结构,包括核仁、Cajal小体、应激颗粒和转录复合体。而 已经进行了许多关于TF相分离的研究,这些研究主要集中在 转录激活因子,而不是转录辅抑制因子,如Ssn6。 本实验室的前期工作表明,C.含有PrLD的白色念珠菌TF容易形成相分离 当纯化时或当在哺乳动物细胞中表达时浓缩。此外,PrLD的缺失或突变可 消除这些TF在C中发挥作用的能力。白色念珠菌细胞我的初步数据显示,Ssn6也能够 单独和与其他真菌TF形成缩合物。我假设相分离是 Ssn6在调节细胞形态中作为辅助阻遏物的能力中的作用,并且它将有助于 OPC期间的毒性。在目标1中,我将研究Ssn6缩合物的生物化学性质。在目标2中,我将 说明Ssn6属性的更改如何影响C。白念珠菌的体外形态型以及毒力, OPC小鼠模型。 此外,该奖学金的目标包括发展技能,以领导一个成功的研究 事业参加会议,向部门和研究生课程介绍,并定期与 赞助商计划为此目的。培训计划将在一个受益于 分子生物学、细胞生物学和生物化学研究生课程。实现拟议目标将 推进念珠菌生物学领域和收件人成为一个有效的独立的能力 科学研究员

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maureen Dowell其他文献

Maureen Dowell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maureen Dowell', 18)}}的其他基金

The role of phase separation in a transcriptional repression mechanism relevant to Candida albicanspathogenesis.
相分离在与白色念珠菌发病机制相关的转录抑制机制中的作用。
  • 批准号:
    10607437
  • 财政年份:
    2022
  • 资助金额:
    $ 4.85万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 4.85万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 4.85万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 4.85万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 4.85万
  • 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了